Sinopharm Group (02005) has obtained the drug production registration certificate for the single-dose packaging of 0.4ml of Ketorolac Tromethamine Eye Drops (0.025%) from the National Medical Products Administration.

Widsom Finance News App: Sihoyao Group (02005) has announced that the group has obtained the drug production registration certificate for the 0.4ml single-dose packaging of Ketotifen Fumarate Ophthalmic Solution (0.025%) from the National Medical Products Administration of China (NMPA), which belongs to the third category of chemical drugs and is considered to have passed consistency evaluation. This product is mainly used for the symptomatic treatment of seasonal allergic conjunctivitis. This product is the second domestically approved product for a domestic enterprise and the third ophthalmic preparation formulation for the group.